Video-Assisted Instruction in Type 2 Diabetes Patients

Education, Patient Clinical Trial

Official title:

The Effect of Video-Assisted Instruction in Type 2 Diabetes Patients' Insulin Self-Management and Insulin Administration Skills

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05926388
• Other study ID #: BU-SBF-EI-001
• Status: Completed
• Phase: N/A
• Start date: January 10, 2022
• Est. completion date: August 10, 2023

Study information

• Verified date: December 2023
• Source: Izmir Bakircay University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study of examine the effect of video-assisted instruction on Type 2 diabetes patients' insulin treatment self-management and insulin administration skills. The research will be conducted as a single group pre-test post-test quasi-experimental study. The sample of the study will be consisted of 50 patients with Type 2 Diabetes. Before the training, the patients will be self-injected a dose of insulin. After giving verbal training, the patients will watch a video recording of insulin treatment and administration. The author will be evaluated the patients' insulin treatment self-management and insulin administration skills after the training.

Description:

The aim of the study of examine the effect of video-assisted instruction on Type 2 diabetes patients' insulin treatment self-management and insulin administration skills. The research will be conducted as a single group pre-test post-test quasi-experimental study. The sample of the study will be consisted of 50 patients with Type 2 Diabetes. Before the training, the patients will be self-injected a dose of insulin. After giving verbal training, the patients will watch a video recording of insulin treatment and administration. The author will be evaluated the patients' insulin treatment self-management and insulin administration skills after the training.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: August 10, 2023
• Est. primary completion date: May 10, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria

• 18-65 years
• No hearing or communication problems
• Self-injecting insulin Exclusion Criteria
• Health care professionals
• Chronic complications
• Pregnant

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 2
• Education, Patient

Intervention

Other:
• Video-assisted training
Patients will be given training on insulin therapy and management using lecture, question-answer, video and demonstration methods.

Locations

Country	Name	City	State
Turkey	izmir Bakircay University	Izmir	Menemen

Sponsors (1)

Lead Sponsor	Collaborator
Izmir Bakircay University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Insulin Treatment Self-Management Scale 1 (Questionnaire)	Patients' self-injection practices will be evaluated.	Seven days after the training
Primary	Insulin Treatment Self-Management Scale 2 (Questionnaire)	Patients' self-injection practices will be evaluated.	Five weeks after the training
Primary	Insulin Administration Observation Form 1	The scale identifies knowledge and skill levels of patients.	Seven days after the training
Primary	Insulin Administration Observation Form 2	The scale identifies knowledge and skill levels of patients.	Five weeks after the training